BIOCARE LIMITED
Get an alert when BIOCARE LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Next accounts due
2026-09-30 (in 4mo)
Last filed for 2024-12-31
Confirmation statement due
2026-07-13 (in 2mo)
Last made up 2025-06-29
Watchouts
None on the register
Cash
£347K
-45.5% vs 2023
Net assets
£10M
+38.9% vs 2023
Employees
51
+4.1% vs 2023
Profit before tax
£4M
+18.4% vs 2023
Name history
Renamed 2 times since incorporation
- BIOCARE LIMITED 1988-05-18 → present
- STIRLING AND DRANSFIELD LIMITED 1986-02-07 → 1988-05-18
- HERBAL TRACERS LIMITED 1985-09-19 → 1986-02-07
Net assets
2-year trend · vs Consumer Staples median
Accounts
2-year trend · latest reflected 2024-12-31
| Metric | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Turnover | £15,911,000 | £16,685,000 | |
| Operating profit | £2,921,000 | £3,182,000 | |
| Profit before tax | £2,969,000 | £3,516,000 | |
| Net profit | £2,286,000 | £2,669,000 | |
| Cash | £637,000 | £347,000 | |
| Total assets less current liabilities | £7,917,000 | £10,423,000 | |
| Net assets | £6,870,000 | £9,539,000 | |
| Equity | £6,870,000 | £9,539,000 | |
| Average employees | 49 | 51 | |
| Wages | £2,833,000 | £2,649,000 |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating margin | 18.4% | 19.1% | |
| Net margin | 14.4% | 16.0% | |
| Return on capital employed | 36.9% | 30.5% | |
| Gearing (liabilities / total assets) | 35.5% | 21.6% | |
| Current ratio | 1.77x | 1.79x | |
| Interest cover | 67.93x | 83.74x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Standalone (parent only)
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The Directors have carried out an assessment of going concern over an 12-month period from when the financial statements are approved with a severe but plausible downside scenario considered in addition to a base case where sales continue to achieve current forecasts. Based on this assessment, the directors have concluded that the Company will have adequate resources to meet its liabilities as they fall due for the foreseeable future.”
Significant events
- “On 11 June 2025 the repayment date for the loan due from Brunel Healthcare Manufacturing Limited was extended to 27 July 2031.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
4 active · 29 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| AMERY, James David | Secretary | 2012-09-21 | — | — |
| AMERY, James David | Director | 2012-09-21 | Nov 1975 | British |
| ELLIS, Emma Louise | Director | 2007-04-18 | Apr 1978 | British |
| OAKLEY, Jason Ronald | Director | 2020-12-23 | Jul 1969 | British |
Show 29 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| DAYE, Kenneth Christopher | Secretary | 1993-03-30 | 2001-10-26 |
| HILTON, Robin David | Secretary | 2005-12-31 | 2012-06-30 |
| QUINN, David John | Secretary | 2005-08-31 | 2005-12-31 |
| STIRLING, Sharon Lee | Secretary | 2001-10-26 | 2005-08-31 |
| STIRLING, Sharon Lee | Secretary | — | 1993-03-30 |
| BRIFFA, John Peter James, Doctor | Director | 1995-11-02 | 1996-12-10 |
| DAYE, Kenneth Christopher | Director | 1996-05-01 | 2001-10-26 |
| DRANSFIELD, Carl William | Director | — | 1992-09-23 |
| FARMER, Thomas John Charles | Director | 2019-01-28 | 2020-05-29 |
| GATTO, Salvatore Martin | Director | 2005-08-31 | 2008-08-31 |
| HAZRA, Debanjan | Director | 2015-11-11 | 2016-12-19 |
| HILTON, Robin David | Director | 2005-11-14 | 2012-06-30 |
| ILYIA, Elias, Dr | Director | 1993-01-04 | 2000-12-31 |
| JOY, Robert Charles | Director | 1999-12-01 | 2005-08-31 |
| LLEWELLYN, Bryan Roland | Director | 2008-09-09 | 2009-06-30 |
| MCEUEN, James Stewart | Director | 2005-11-14 | 2016-10-24 |
| MYERS, Raymond John | Director | 2008-06-17 | 2011-12-31 |
| O'BRIEN, Lauren Margaret | Director | 2013-10-10 | 2017-08-31 |
| PLUMMER, Nigel Terrance | Director | 1993-01-04 | 2005-08-31 |
| QUILT, Peter, Doctor | Director | 1995-10-06 | 2005-08-31 |
| SIDDIQUI, Saud Hafeez, Mr. | Director | 2015-11-24 | 2016-12-19 |
| STIRLING, John Kenneth | Director | 1996-07-09 | 2005-08-31 |
| STIRLING, John Kenneth | Director | 1996-06-18 | 1996-07-08 |
| STIRLING, Sharon Lee | Director | 2006-09-01 | 2008-08-31 |
| STIRLING, Sharon Lee | Director | — | 2005-08-31 |
| TOXVAERD, Michael Hjelm | Director | 2005-08-31 | 2009-01-14 |
| WARD, Mark Kingsley | Director | 2006-09-01 | 2008-08-31 |
| WARD, Mark Kingsley | Director | 2001-10-22 | 2005-08-31 |
| WHITE, Karen Louise | Director | 2006-09-01 | 2010-01-25 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Mr Yuanlin Ren | Individual | Shares 25–50% | 2016-12-30 | Ceased 2017-06-30 |
| Mr Liang Chang | Individual | Shares 50–75% | 2016-12-19 | Active |
Filing timeline
Last 20 of 234 total filings
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2025-07-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-07 | AA | accounts | Accounts with accounts type full | |
| 2024-12-13 | PSC04 | persons-with-significant-control | Change to a person with significant control | |
| 2024-08-20 | AA | accounts | Accounts with accounts type full | |
| 2024-07-10 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2023-09-06 | AA | accounts | Accounts with accounts type full | |
| 2023-07-08 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-06-30 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2022-06-27 | AA | accounts | Accounts with accounts type full | |
| 2021-07-13 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2021-07-07 | AA | accounts | Accounts with accounts type full | |
| 2020-12-23 | AP01 | officers | Appoint person director company with name date | |
| 2020-10-01 | AA | accounts | Accounts with accounts type full | |
| 2020-07-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2020-06-18 | AD01 | address | Change registered office address company with date old address new address | |
| 2020-06-09 | TM01 | officers | Termination director company with name termination date | |
| 2019-09-30 | AA | accounts | Accounts with accounts type full | |
| 2019-07-01 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2019-01-28 | AP01 | officers | Appoint person director company with name date | |
| 2018-08-22 | AA | accounts | Accounts with accounts type full |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 2
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.
Year-on-year
FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31
-
Turnover
+4.9%
£15,911,000 £16,685,000
-
Cash
-45.5%
£637,000 £347,000
-
Net assets
+38.9%
£6,870,000 £9,539,000
-
Employees
+4.1%
49 51
-
Operating profit
+8.9%
£2,921,000 £3,182,000
-
Profit before tax
+18.4%
£2,969,000 £3,516,000
-
Wages
-6.5%
£2,833,000 £2,649,000
Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers